CYTK:NASDAQ
Cytokinetics, Inc.
$65.62
arrow_downward
-0.44%(-0.29) 1D
$65.62
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 1, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$65.73
High
$67.27
Low
$65.30
Mkt. cap
9.12B
Avg. vol.
1.99M
Volume
1.16M
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
Open
$65.73
High
$67.27
Low
$65.30
Mkt. cap
9.12B
Avg. vol.
1.99M
Volume
1.16M
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
AD HOC NEWS
·
4 hours ago
Cytokinetics launches ASPEN-HCM and analysts rate Cytokinetics stock a Buy
Simply Wall Street
·
22 hours ago
Is Real World Study Launch Altering The Investment Case For Cytokinetics (CYTK)?
GuruFocus
·
1 day ago
Cytokinetics (CYTK) Launches ASPEN-HCM Study to Evaluate Myqorzo in Obstructive Hypertrophic Cardiomyopathy
Stock Titan
·
1 day ago
A new study aims to enroll about 400 adults to assess a heart drug in everyday care.
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com